Cargando…
Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
As one of the most common types of pancreatic cancer, pancreatic ductal adenocarcinoma (PDAC) is highly invasive and lethal. This study aims to develop biomarkers and targets for the diagnosis and treatment of PDAC. Differentially expressed genes (DEGs) were screened via GEO2R, protein network was c...
Autores principales: | Zeng, Yinzhen, Fan, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515086/ https://www.ncbi.nlm.nih.gov/pubmed/36167975 http://dx.doi.org/10.1038/s41598-022-20615-8 |
Ejemplares similares
-
CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020) -
Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma
por: Xia, Tian, et al.
Publicado: (2021) -
CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a
bioinformatics study
por: Li, An-hai, et al.
Publicado: (2022) -
CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor
por: Xiang, Bin, et al.
Publicado: (2023) -
Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
por: Cao, Jintao, et al.
Publicado: (2021)